Tonghua Dongbao Pharmaceutical Co Ltd
SSE:600867
Intrinsic Value
Tonghua Dongbao Pharmaceutical Co., Ltd. is engaged in the manufacture, distribution, research and development of pharmaceuticals. [ Read More ]
The intrinsic value of one Tonghua Dongbao Pharmaceutical Co Ltd stock under the Base Case scenario is 13.98 CNY. Compared to the current market price of 10.18 CNY, Tonghua Dongbao Pharmaceutical Co Ltd is Undervalued by 27%.
Valuation Backtest
Tonghua Dongbao Pharmaceutical Co Ltd
Run backtest to discover the historical profit from buying and selling Tonghua Dongbao Pharmaceutical Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Tonghua Dongbao Pharmaceutical Co Ltd
| Current Assets | 2.8B |
| Cash & Short-Term Investments | 1.2B |
| Receivables | 916.8m |
| Other Current Assets | 739.8m |
| Non-Current Assets | 5B |
| Long-Term Investments | 534.2m |
| PP&E | 2.7B |
| Intangibles | 1.3B |
| Other Non-Current Assets | 378.1m |
| Current Liabilities | 520.2m |
| Accounts Payable | 115.9m |
| Accrued Liabilities | 31.2m |
| Short-Term Debt | 150m |
| Other Current Liabilities | 223.1m |
| Non-Current Liabilities | 40m |
| Other Non-Current Liabilities | 40m |
Earnings Waterfall
Tonghua Dongbao Pharmaceutical Co Ltd
|
Revenue
|
3.1B
CNY
|
|
Cost of Revenue
|
-621.5m
CNY
|
|
Gross Profit
|
2.5B
CNY
|
|
Operating Expenses
|
-1.2B
CNY
|
|
Operating Income
|
1.3B
CNY
|
|
Other Expenses
|
-104.2m
CNY
|
|
Net Income
|
1.2B
CNY
|
Free Cash Flow Analysis
Tonghua Dongbao Pharmaceutical Co Ltd
Profitability Score
Profitability Due Diligence
Tonghua Dongbao Pharmaceutical Co Ltd's profitability score is 67/100. The higher the profitability score, the more profitable the company is.
Score
Tonghua Dongbao Pharmaceutical Co Ltd's profitability score is 67/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Tonghua Dongbao Pharmaceutical Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Score
Tonghua Dongbao Pharmaceutical Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Tonghua Dongbao Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for Tonghua Dongbao Pharmaceutical Co Ltd is 16.85 CNY with a low forecast of 11.53 CNY and a high forecast of 29.33 CNY.
Shareholder Return
Price
Tonghua Dongbao Pharmaceutical Co Ltd
| Average Annual Return | -9.33% |
| Standard Deviation of Annual Returns | 8.43% |
| Max Drawdown | -53% |
| Market Capitalization | 20.3B CNY |
| Shares Outstanding | 1 978 084 146 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Tonghua Dongbao Pharmaceutical Co., Ltd. is engaged in the manufacture, distribution, research and development of pharmaceuticals. The company is headquartered in Tonghua, Jilin and currently employs 2,814 full-time employees. The firm provides biological products, traditional Chinese medicines and chemical supplements, applied in the treatment of diabetes and cardiovascular and cerebrovascular diseases, among others. The firm's main products portfolio consists of recombinant human insulin bulk drugs and injections, zhennaoning capsules, among others. The firm also provides medical instruments, plastic-steel windows and profiles, and operates property business. The firm distributes its products within domestic markets and to overseas markets.
Contact
IPO
Employees
Officers
The intrinsic value of one Tonghua Dongbao Pharmaceutical Co Ltd stock under the Base Case scenario is 13.98 CNY.
Compared to the current market price of 10.18 CNY, Tonghua Dongbao Pharmaceutical Co Ltd is Undervalued by 27%.
You don't have any saved screeners yet
